Synaptogenix, Inc.
SNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $6 | $6 | $6 | $5 |
| Gross Profit | -$6 | -$6 | -$6 | -$5 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,599 | $1,975 | $6,325 | $4,336 |
| G&A Expenses | $5,212,010,000 | $6,339 | $9,810 | $8,282 |
| SG&A Expenses | $5,206 | $6,339 | $9,810 | $8,282 |
| Sales & Mktg Exp. | -$5,212,004,794 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $6,805 | $8,314 | $16,135 | $12,618 |
| Operating Income | -$6,811 | -$8,314 | -$26,361 | -$12,618 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$5,958 | $2,275 | $10,561 | $7 |
| Pre-Tax Income | -$12,769 | -$6,039 | -$5,574 | -$12,611 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12,769 | -$6,039 | -$5,458 | -$12,604 |
| % Margin | – | – | – | – |
| EPS | -10.99 | -29.56 | -20.35 | -62.87 |
| % Growth | 62.8% | -45.3% | 67.6% | – |
| EPS Diluted | -10.99 | -29.56 | -20.35 | -62.87 |
| Weighted Avg Shares Out | 1,234 | 466 | 273 | 200 |
| Weighted Avg Shares Out Dil | 1,234 | 466 | 280 | 201 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,276 | $1,649 | $335 | $7 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $6 | $6 | $5 |
| EBITDA | -$12,763 | -$8,308 | -$16,129 | -$12,613 |
| % Margin | – | – | – | – |